RadNet Promotes Four Executives to Drive Strategic Growth
RadNet announced the promotion of four senior leaders to expanded executive roles in recognition of their decades of operational excellence and strategic growth. Effective immediately, the executive leadership changes include: Stephen Forthuber, President and Chief Operating Officer, Eastern Operations, to President and Chief Executive Officer, Eastern Operations. Norman Hames, President and Chief Operating Officer, Western Operations, to President and Chief Executive Officer, Western Operations. Mital Patel, Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer, to Executive Vice President and Chief Operating Officer. Greg Sorensen, M.D., Chief Science Officer to Chief Strategy Officer. Dr. Sorensen will continue to serve as a member of RadNet's Board of Directors.
Get Free Real-Time Notifications for Any Stock
Analyst Views on RDNT
About RDNT
About the author

Rapid Growth in Cardiac AI Diagnostics Market
- Market Surge: The global medical imaging market reached $45.5 billion in 2026, indicating a significant shift towards AI-native precision, particularly due to the rising demand for heart monitoring in cancer treatments.
- Rise of Cardiac AI Diagnostics: The cardiac AI diagnostics sector hit $2.22 billion in 2026, driven by the urgent need for continuous imaging to monitor heart dysfunction, enhancing the company's competitive edge in the medical technology market.
- Strategic Partnership Enhances Value: Ventripoint's collaboration with Summit Sciences to develop ROI models illustrates how hospitals can achieve cost savings through technological improvements, further solidifying its market position in cardiac care.
- Executive Appointment Fuels Growth: The appointment of David Swetlow as CFO, with extensive experience in medical technology, is expected to accelerate market adoption and revenue growth, driving the execution of the company's commercial strategy.

Rapid Growth in Cardiac AI Diagnostics Market
- Market Size Surge: The global medical imaging market reached $45.5 billion in 2026, indicating a significant shift towards AI-driven precision, with the cardiac AI diagnostics sector hitting $2.22 billion, reflecting a critical demand for continuous imaging.
- Technological Innovation: VentriPoint Diagnostics is transforming standard 2D ultrasound images into MRI-level 3D heart models, significantly reducing costs and complexity, which is expected to drive rapid growth in its subscription business.
- Surge in Investment Demand: The company recently doubled its private placement from $500,000 to $1 million, with funds allocated for commercialization and market expansion, showcasing strong investor confidence in its technology and market potential.
- Strategic Partnership: VentriPoint's collaboration with Summit Sciences to develop ROI models aims to demonstrate the economic value of its technology to hospitals, further solidifying its market position in medical imaging.









